Male Wistar rats, weighing 200250 g and aged 910 weeks were housed in groups of three under controlled environmental conditions at the Center for Genetic Engineering and Biotechnology (CIGB), with free access to food and water

Cagrilintide: Long-acting amylin analog explained What cagrilintide is: Synthetic analog of human amylin hormone Also called "pramlintide long-acting" (related compound) Developed by Novo Nordisk Currently investigational (Phase 3 trials) Not yet FDA approved (as of 2024) Weekly subcutaneous injection Natural amylin background: Peptide hormone co-secreted with insulin Made by pancreatic beta cells Released after meals in response to nutrients Important satiety signal Regulates postprandial glucose Deficient in diabetes Why synthetic cagrilintide was developed: Natural amylin very short half-life (minutes) Impractical for treatment Cagrilintide engineered for long duration Weekly dosing vs multiple daily injections Better pharmacokinetics Enhanced stability Learn about peptides , how peptides work , and what are peptides used for at SeekPeptides

By bunching up the skin, you create a thicker area of fat for you to inject into, ensuring the entire dose is administered into the fat and not into the underlying muscle
This is to check for any immediate adverse reactions
Remove syringe and needle: After injecting water, remove the syringe and needle carefully
Parsons RB, Facey PD (2021) Nicotinamide N -methyltransferase: an emerging protagonist in cancer macro (r) evolution